Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: Role of gemfibrozil

Journal of Lipid Research

Volumn 39, Issue 2, 1998, Pages 255-267

  Mohan, William S ^a   Chen, Zhang Qun ^a   Zhang, Xia ^a   Khalili, Kamel ^b   Honjo, Tasuku ^c   Deeley, Roger G ^a   Tam, Shui Pang ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Apolipoprotein A I; Gemfibrozil; Gene expression; Regulatory sequence; Transcription factor

Indexed keywords

BINDING PROTEIN; GEMFIBROZIL;

ARTICLE; CHOLESTEROL TRANSPORT; DNA FOOTPRINTING; DRUG RECEPTOR BINDING; GEL MOBILITY SHIFT ASSAY; HEPATOMA CELL; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; STEROIDOGENESIS; TRANSACTIVATION;

ANTILIPEMIC AGENTS; APOLIPOPROTEIN A-I; BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; DNA-BINDING PROTEINS; GEMFIBROZIL; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031935578     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Gotto, A. M., H. J. Pownall, and R. J. Havel. 1986. Introduction to the plasma lipoproteins. [Review]. Methods Enzymol. 128: 3-41.
2. Miller, N. E., A. LaVille, and D. Crook. 1985. Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit. Nature. 314: 109-111.
3. Glomset, J. A. 1980. High-density lipoproteins in human health and disease. [Review]. Adv. Intern. Med. 25: 91-116.
4. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and R. Dawber. 1981. Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch. Intern. Med. 141: 1128-1131.
5. Sniderman, A. D. 1988. Apolipoprotein B and apolipo-protein A-I as predictors of coronary artery disease. [Review]. Can. J. Cardiol. 4: Suppl A: 24A-30A.
6. Rubin, E. M., R. M. Krauss, E. A. Spangle, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 353: 265-267.
7. Plump, A. S., S. K. Erickson, W. Weng, J. S. Partin, J. L. Breslow, and D. L. Williams. 1996. Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J. Clin. Invest 97: 2660-2671.
8. Higuchi, K., W. W. Law, J. M. Hoeg, U. K. Schumacher, N. Meglin, and H. B. Brewer, Jr. 1988. Tissue-specific expression of apolipoprotein A-I (apoA-I) is regulated by the 5′-flanking region of the human apoA-I gene. J. Biol. Chem. 263: 18530-18536.
9. Sastry, K. N., V. Seedorf, and S. K. Karathanasis. 1991. Different cis-acting DNA elements control expression of the human apolipoprotein A-I gene in different cell types. Mol. Cell. Biol. 8: 605-614.
10. 3. J. Biol. Chem. 264: 6488-6494.
11. Widom, R. L., J. A. A. Ladias, S. Kouidou, and S. K. Karathanasis. 1991. Synergistic interactions between transcription factors control expression of the apolipoprotein A-I gene in liver cells. Mol. Cell. Biol. 12: 677-687.
12. Papazafiri, P., K. Ogami, D. P. Ramji, A. Nicosia, P. Monaci, C. Cladaras, and V. I. Zannis. 1991. Promoter elements and factors involved in hepatic transcription of the human apoA-I gene positive and negative regulators bind to overlapping sites. J. Biol. Chem. 266: 5790-5797.
13. Ladias, J. A., and S. K. Karathanasis. 1991. Regulation of the apolipoprotein A-I gene by ARP-1, a novel member of the steroid receptor superfamily. Science. 251: 561-565.
14. Sladek, F. M., W. M. Zhong, E. Lai, and J. E. Darnell, Jr. 1990. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes & Dev. 4: 2353-2365.
15. Chan, J., H. Nakabayashi, and N. C. W. Wong. 1993. HNF-4 increases activity of the rat apoA-I gene. Nucleic Acids Res. 21: 1205-1211.
16. Rottman, J. N., R. L. Widom, B. Nadal-Ginard, V. Mahdavi, and S. K. Karathanasis. 1991. A retinoic acid-responsive element in the apolipoprotein A-I gene distinguishes between two different retinoic acid response pathways. Mol. Cell. Biol. 11: 3814-3820.
17. Widom, R. L., R. Myungchuli, and S. K. Karathanasis. 1992. Repression by ARP-1 sensitizes apolipoprotein A-I gene responsiveness to RXRα and retinoic acid. Mol. Cell. Biol. 12: 3380-3389.
18. Vu-Dac, N., K. Schoonjans, B. Laine, J. C. Fruchart, J. Auwerx, and B. Staels. 1994. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J. Biol. Chem. 269: 31012-31018.
19. Harnish, D. C., S. Malik, and S. K. Karathanasis. 1994. Activation of apolipoprotein A-I gene transcription by the liver-enriched factor HNF-3. J. Biol. Chem. 269: 28220-28226.
20. Tzameli, I., and V. I. Zannis. 1996. Binding specificity and modulation of the apoA-I promoter activity by homo- and heterodimers of nuclear receptors. J. Biol. Chem. 271: 8402-8415.
21. Tam, S-P. 1991. Effects of gemfibrozil and ketoconazole on human apolipoprotein A-I, B and E levels in two hepatoma cell lines, HepG2 and Hep3B. Atherosclerosis. 91: 51-61.
22. Zhang, X., Z-Q. Chen, Z. Wang, W. S. Mohan, and S-P. Tam. 1996. Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene. J. Biol. Chem. 271: 27152-27160.
23. Sogawa, K., A. Fujisawa-Sehara, M. Yamane, and Y. Fujii-Kuriyama. 1986. Location of regulatory elements responsible for drug induction in the rat cytochrome P-450c gene. Proc. Natl. Acad. Sci, USA. 83: 8044-8048.
24. Kerr, D., and K. Khalili. 1991. A recombinant cDNA derived from human brain encodes a DNA binding protein that stimulates transcription of the human neurotropic virus JCV. J. Biol. Chem. 266: 15876-15881.
25. Fukita, Y., T-R. Mizuta, M. Shirozu, K. Ozawa, A. Shimizu, and T. Honjo. 1993. The human SμBP-2, a DNA-binding protein specific to the single stranded guanine-rich sequence related to the immunoglobulin μ chain switch region. J. Biol. Chem. 268: 17463-17470.
26. Mizuta, T-R., Y. Fukita, T. Miyoshi, A. Shimizu, and T. Honjo. 1993. Isolation of cDNA encoding a binding protein specific to 5′-phosphorylated single-stranded DNA with G-rich sequences. Nucleic Acids Res. 21: 1761-1766.
27. Fujisawa-Sehara, A., K. Sogawa, M. Yamane, and Y. Fujii-Kuriyama. 1987. Characterization of xenobiotic responsive elements upstream from the drug-metabolizing cytochrome P450 c gene: a similarity to glucocorticoid regulatory elements. Nucleic Acids Res. 15: 4179-4191.
28. Li, Y., and A. K. Jaiswal. 1992. Regulation of human AND (P) H:quinone oxidoreductase gene. J. Biol. Chem. 267: 15097-15104.
29. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1051.
30. Tam, S-P. 1992. Effect of ethanol on lipoprotein secretion in two human hepatoma cell lines, HepG2 and Hep3B. Alcohol. Clin. Exp. Res. 16: 1021-1028.
31. Groger, R. K., D. M. Morrow, and M. L. Tykocinski. 1989. Directional antisense and sense cDNA cloning using Epstein-Barr and virus episomal expression vectors. Gene. 81: 285-294.
32. Wilson, G. M., and R. G. Deeley. 1995. An episomal expression vector system for monitoring sequence-specific effects on mRNA stability in human cell lines. Plasmid. 33: 198-207.
33. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1991. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory. Cold Spring Harbor, New York. 7.1-7.87.
35. Tso, J. Y., X-H. Sun, T. Kao, K. S. Reece, and R. Wu. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids. Res. 13: 2485-2502.
36. Vinson, C., L. L. LaMarco, P. G. Johnson, W. H. Landschulz, and S. L. McKnight. 1988. In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage. Genes & Dev. 2: 801-806.
37. Singh, H., R. G. Clerc, and J. H. LeBowitz. 1988. Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA. Cell. 52: 415-423.
38. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74: 5463-5467.
39. Shieh, S-Y., C. M. M. Stellrecht, and M-J. Tsai. 1995. Molecular characterization of the rat insulin enhancer-binding complex 3b2. J. Biol. Chem. 270: 21503-21508.
40. Sebastiani, G., D. Durocher, P. Gros, M. Nemer, and D. Malo. 1995. Localization of the Catfl transcription factor gene to mouse chromosome 19. Mammal. Genome. 6: 147-148.
41. Frick, M. H., O. Elo, K. Happa, O. P. Heinonen, P. Heinsalmi, P. Helo, J. K. Huttunen, Kaitaniemi, P. Koskinen, V. Mannien, H. Maenpaa, M. Malkonen, M. Manttari, S. Norola, A. Pasternack, J. Pikkarainen, M. Romo, T. Sjoblom, and E. A. Nikkila. 1987. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med. 317: 1237-1245.
42. Isseman, I., and S. Green. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347: 645-650.
43. Sher, T., H. F. Yi. O. W. McBride, and F. J. Gonzales. 1993. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 32: 5598-5604.
44. Zhu, Y., K. Alvares, Q. Huang, M. S. Rao, and J. K. Reddy. 1993. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J. Biol. Chem. 268: 26817-26820.
45. Tugwood, J. D., I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, and S. Green. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11: 433-439.
46. Zhang, B., S. L. Marcus, F. G. Sajjadi, K. Alvares, J. K. Reddy, S. Subramani, R. A. Rachubinski, and J. P. Capone. 1992. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl. Acad. Sci. USA. 89: 7541-7545.
47. Bardot, O., T. C. Aldridge, N. Latruffe, and S. Green. 1993. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun. 192: 37-45.
48. Muerhoff, A. S., K. J. Griffin, and F. F. Johnson. 1992. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J. Biol. Chem. 267: 19051-19053.
49. Palmer, C. N., M. H. Hsu, A. S. Muerhoff, K. J. Griffin, and F. F. Johnson. 1994. Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response that overlaps an ARP-1 binding site in the CYP4A6 promoter. J. Biol. Chem. 269: 18083-18089.
50. De La Inglesia, F. A., J. E. Lewis, R. A. Buchanan, E. L. Marcus, and G. McMahon. 1982. Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis. 43: 19-37.
51. Kockx, M., H. M. G. Princen, and T. Kooistra. 1996. Studies on the role of PPAR in the fibrate-modulated gene expression of apolipoprotein A-I, plasminogen activator inhibitor 1, and fibrinogen in primary hepatocyte cultures from cynomolgus monkey. Ann. NY Acad. Sci. 804: 711-712.
52. McBride, K., K. Robitaille, S. Tremblay, S. Argentin, and M. Nemer. 1993. fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element. Mol. Cell. Biol. 13: 600-612.
53. Khavari, P. A., C. L. Peterson, J. W. Tamkun, D. B. Mendel, and G. R. Crabtree. 1993. BRG1 contains a conserved domain of the SW12/SNF2 family necessary for normal mitotic growth and transcription. Nature. 366: 170-174.
54. Davis, J. L., R. Kunisawa, and J. Thorner. 1992. A presumptive helicase (MOT1 gene product) affects gene expression and is required for viability in the yeast Saccharomyces cerervisiae. Mol. Cell. Biol. 12: 1879-1892.
55. Laurent, B. C., X. Yang, and M. Carlson. 1992. An essential Saccharomyces cerevisiae gene homologous to SNF2 encodes a helicase-related protein in a new family. Mol. Cell. Biol. 12: 1893-1902.
56. Roberts, E. A., M. Letarte, J. Squire, and S. Yang. 1994. Characterization of human hepatocyte lines derived from normal liver. Hepatology. 19: 1390-1399.